|
|||||
|
|
Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy |
|
| Authors: | Richard M. Gibson Jan Weber Dane Winner Michael D. Miller Miguel E. Qui?ones-Mateu |
| Affiliation: | 1. University Hospital Translational Laboratory, University Hospitals Case Medical Center, Cleveland, Ohio, United States of America.; 2. Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic.; 3. Gilead Sciences, Inc., Foster City, California, United States of America.; 4. Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.; University of Pittsburgh, United States of America, |
| Abstract: | |
| Keywords: | |